COVID-19 Impact on Global Gene Amplification Technologies Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Gene Amplification Technologies Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Gene Amplification Technologies Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Polymerase Chain Reaction (PCR)
- 1.4.3 Loop Mediated Isothermal Amplification (LAMP)
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Gene Amplification Technologies Market Share by Application: 2020 VS 2026
- 1.5.2 Medical
- 1.5.3 Forensics
- 1.5.4 Paternity
- 1.5.5 Personnel Identification
- 1.5.6 Food safety
- 1.5.7 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Gene Amplification Technologies Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Amplification Technologies Industry
- 1.6.1.1 Gene Amplification Technologies Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Gene Amplification Technologies Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Gene Amplification Technologies Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Amplification Technologies Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Gene Amplification Technologies Market Perspective (2015-2026)
- 2.2 Gene Amplification Technologies Growth Trends by Regions
- 2.2.1 Gene Amplification Technologies Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Gene Amplification Technologies Historic Market Share by Regions (2015-2020)
- 2.2.3 Gene Amplification Technologies Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Gene Amplification Technologies Market Growth Strategy
- 2.3.6 Primary Interviews with Key Gene Amplification Technologies Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Gene Amplification Technologies Players by Market Size
- 3.1.1 Global Top Gene Amplification Technologies Players by Revenue (2015-2020)
- 3.1.2 Global Gene Amplification Technologies Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Gene Amplification Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Gene Amplification Technologies Market Concentration Ratio
- 3.2.1 Global Gene Amplification Technologies Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Gene Amplification Technologies Revenue in 2019
- 3.3 Gene Amplification Technologies Key Players Head office and Area Served
- 3.4 Key Players Gene Amplification Technologies Product Solution and Service
- 3.5 Date of Enter into Gene Amplification Technologies Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Gene Amplification Technologies Historic Market Size by Type (2015-2020)
- 4.2 Global Gene Amplification Technologies Forecasted Market Size by Type (2021-2026)
5 Gene Amplification Technologies Breakdown Data by Application (2015-2026)
- 5.1 Global Gene Amplification Technologies Market Size by Application (2015-2020)
- 5.2 Global Gene Amplification Technologies Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Gene Amplification Technologies Market Size (2015-2020)
- 6.2 Gene Amplification Technologies Key Players in North America (2019-2020)
- 6.3 North America Gene Amplification Technologies Market Size by Type (2015-2020)
- 6.4 North America Gene Amplification Technologies Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Gene Amplification Technologies Market Size (2015-2020)
- 7.2 Gene Amplification Technologies Key Players in Europe (2019-2020)
- 7.3 Europe Gene Amplification Technologies Market Size by Type (2015-2020)
- 7.4 Europe Gene Amplification Technologies Market Size by Application (2015-2020)
8 China
- 8.1 China Gene Amplification Technologies Market Size (2015-2020)
- 8.2 Gene Amplification Technologies Key Players in China (2019-2020)
- 8.3 China Gene Amplification Technologies Market Size by Type (2015-2020)
- 8.4 China Gene Amplification Technologies Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Gene Amplification Technologies Market Size (2015-2020)
- 9.2 Gene Amplification Technologies Key Players in Japan (2019-2020)
- 9.3 Japan Gene Amplification Technologies Market Size by Type (2015-2020)
- 9.4 Japan Gene Amplification Technologies Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Gene Amplification Technologies Market Size (2015-2020)
- 10.2 Gene Amplification Technologies Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Gene Amplification Technologies Market Size by Type (2015-2020)
- 10.4 Southeast Asia Gene Amplification Technologies Market Size by Application (2015-2020)
11 India
- 11.1 India Gene Amplification Technologies Market Size (2015-2020)
- 11.2 Gene Amplification Technologies Key Players in India (2019-2020)
- 11.3 India Gene Amplification Technologies Market Size by Type (2015-2020)
- 11.4 India Gene Amplification Technologies Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Gene Amplification Technologies Market Size (2015-2020)
- 12.2 Gene Amplification Technologies Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Gene Amplification Technologies Market Size by Type (2015-2020)
- 12.4 Central & South America Gene Amplification Technologies Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Abbott Laboratories
- 13.1.1 Abbott Laboratories Company Details
- 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
- 13.1.3 Abbott Laboratories Gene Amplification Technologies Introduction
- 13.1.4 Abbott Laboratories Revenue in Gene Amplification Technologies Business (2015-2020))
- 13.1.5 Abbott Laboratories Recent Development
- 13.2 QIAGEN
- 13.2.1 QIAGEN Company Details
- 13.2.2 QIAGEN Business Overview and Its Total Revenue
- 13.2.3 QIAGEN Gene Amplification Technologies Introduction
- 13.2.4 QIAGEN Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.2.5 QIAGEN Recent Development
- 13.3 Agilent Technologies
- 13.3.1 Agilent Technologies Company Details
- 13.3.2 Agilent Technologies Business Overview and Its Total Revenue
- 13.3.3 Agilent Technologies Gene Amplification Technologies Introduction
- 13.3.4 Agilent Technologies Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.3.5 Agilent Technologies Recent Development
- 13.4 Bayer Corporation
- 13.4.1 Bayer Corporation Company Details
- 13.4.2 Bayer Corporation Business Overview and Its Total Revenue
- 13.4.3 Bayer Corporation Gene Amplification Technologies Introduction
- 13.4.4 Bayer Corporation Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.4.5 Bayer Corporation Recent Development
- 13.5 Rubicon Genomics
- 13.5.1 Rubicon Genomics Company Details
- 13.5.2 Rubicon Genomics Business Overview and Its Total Revenue
- 13.5.3 Rubicon Genomics Gene Amplification Technologies Introduction
- 13.5.4 Rubicon Genomics Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.5.5 Rubicon Genomics Recent Development
- 13.6 BD
- 13.6.1 BD Company Details
- 13.6.2 BD Business Overview and Its Total Revenue
- 13.6.3 BD Gene Amplification Technologies Introduction
- 13.6.4 BD Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.6.5 BD Recent Development
- 13.7 Roche Diagnostics
- 13.7.1 Roche Diagnostics Company Details
- 13.7.2 Roche Diagnostics Business Overview and Its Total Revenue
- 13.7.3 Roche Diagnostics Gene Amplification Technologies Introduction
- 13.7.4 Roche Diagnostics Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.7.5 Roche Diagnostics Recent Development
- 13.8 BioMerieux
- 13.8.1 BioMerieux Company Details
- 13.8.2 BioMerieux Business Overview and Its Total Revenue
- 13.8.3 BioMerieux Gene Amplification Technologies Introduction
- 13.8.4 BioMerieux Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.8.5 BioMerieux Recent Development
- 13.9 Bio-Rad Laboratories
- 13.9.1 Bio-Rad Laboratories Company Details
- 13.9.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
- 13.9.3 Bio-Rad Laboratories Gene Amplification Technologies Introduction
- 13.9.4 Bio-Rad Laboratories Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.9.5 Bio-Rad Laboratories Recent Development
- 13.10 Cepheid
- 13.10.1 Cepheid Company Details
- 13.10.2 Cepheid Business Overview and Its Total Revenue
- 13.10.3 Cepheid Gene Amplification Technologies Introduction
- 13.10.4 Cepheid Revenue in Gene Amplification Technologies Business (2015-2020)
- 13.10.5 Cepheid Recent Development
- 13.11 Life Technologies
- 10.11.1 Life Technologies Company Details
- 10.11.2 Life Technologies Business Overview and Its Total Revenue
- 10.11.3 Life Technologies Gene Amplification Technologies Introduction
- 10.11.4 Life Technologies Revenue in Gene Amplification Technologies Business (2015-2020)
- 10.11.5 Life Technologies Recent Development
- 13.12 Takara Bio
- 10.12.1 Takara Bio Company Details
- 10.12.2 Takara Bio Business Overview and Its Total Revenue
- 10.12.3 Takara Bio Gene Amplification Technologies Introduction
- 10.12.4 Takara Bio Revenue in Gene Amplification Technologies Business (2015-2020)
- 10.12.5 Takara Bio Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
This report focuses on the global Gene Amplification Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Amplification Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories
QIAGEN
Agilent Technologies
Bayer Corporation
Rubicon Genomics
BD
Roche Diagnostics
BioMerieux
Bio-Rad Laboratories
Cepheid
Life Technologies
Takara Bio
Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Loop Mediated Isothermal Amplification (LAMP)
Other
Market segment by Application, split into
Medical
Forensics
Paternity
Personnel Identification
Food safety
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gene Amplification Technologies status, future forecast, growth opportunity, key market and key players.
To present the Gene Amplification Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Gene Amplification Technologies are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.